These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17899704)

  • 1. [Recurrence risk analysis in patients treated for I clinical stage of endometrial cancer].
    Bidziński M; Dańska-Bidzińska A; Derlatka P; Sobiczewski P; Gmyrek L; Jońska-Gmyrek J; Panek G
    Ginekol Pol; 2007 Jun; 78(6):471-5. PubMed ID: 17899704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
    Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
    Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
    Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
    Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent.
    Rajasooriyar C; Bernshaw D; Kondalsamy-Chennakesavan S; Mileshkin L; Narayan K
    J Gynecol Oncol; 2014 Oct; 25(4):313-9. PubMed ID: 25142629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
    Ivanov S; Tomov S
    Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
    Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
    Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.
    Chuang L; Burke TW; Tornos C; Marino BD; Mitchell MF; Tortolero-Luna G; Levenback C; Morris M; Gershenson DM
    Gynecol Oncol; 1995 Aug; 58(2):189-93. PubMed ID: 7622103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between pretreatment prognostic factors and lymph node metastases in endometrial adenocarcinoma. Clinical application.
    La Fianza A; Alberici E; Generoso P; Preda L; Campani R
    Radiol Med; 2000 Nov; 100(5):363-6. PubMed ID: 11213416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
    Koskas M; Rouzier R; Amant F
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):845-57. PubMed ID: 25817745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.